

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine metabolic process (GO:0006558) | 6.53207323 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.53207323 |
| 3 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 6.51285557 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.46248171 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.46248171 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.99490171 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.75248818 |
| 8 | ATP synthesis coupled proton transport (GO:0015986) | 5.61263457 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.61263457 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.57452626 |
| 11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.35564130 |
| 12 | respiratory electron transport chain (GO:0022904) | 5.17578349 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.17261162 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 5.17261162 |
| 15 | tryptophan catabolic process (GO:0006569) | 5.17261162 |
| 16 | electron transport chain (GO:0022900) | 5.07492749 |
| 17 | cysteine metabolic process (GO:0006534) | 5.01811008 |
| 18 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 5.00406088 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.95654295 |
| 20 | lysine catabolic process (GO:0006554) | 4.95389144 |
| 21 | lysine metabolic process (GO:0006553) | 4.95389144 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.94836308 |
| 23 | protein complex biogenesis (GO:0070271) | 4.94172904 |
| 24 | chaperone-mediated protein transport (GO:0072321) | 4.92073341 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.87700755 |
| 26 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.82017159 |
| 27 | bile acid biosynthetic process (GO:0006699) | 4.74676247 |
| 28 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.67499816 |
| 29 | regulation of mitochondrial translation (GO:0070129) | 4.59239860 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.52974663 |
| 31 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.47973472 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.46421692 |
| 33 | cellular ketone body metabolic process (GO:0046950) | 4.45951491 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 4.38979879 |
| 35 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.35034731 |
| 36 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.35034731 |
| 37 | NADH dehydrogenase complex assembly (GO:0010257) | 4.35034731 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.32158263 |
| 39 | deoxyribonucleotide catabolic process (GO:0009264) | 4.29472438 |
| 40 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 4.29337147 |
| 41 | ribosomal small subunit biogenesis (GO:0042274) | 4.24614146 |
| 42 | short-chain fatty acid metabolic process (GO:0046459) | 4.24443014 |
| 43 | alpha-linolenic acid metabolic process (GO:0036109) | 4.22610054 |
| 44 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.17120359 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.15954732 |
| 46 | valine metabolic process (GO:0006573) | 4.15266435 |
| 47 | proteasome assembly (GO:0043248) | 4.14376214 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.13031208 |
| 49 | fatty acid beta-oxidation (GO:0006635) | 4.12886419 |
| 50 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.12097215 |
| 51 | urea metabolic process (GO:0019627) | 4.09637472 |
| 52 | urea cycle (GO:0000050) | 4.09637472 |
| 53 | protein maturation by protein folding (GO:0022417) | 4.09341319 |
| 54 | regulation of triglyceride catabolic process (GO:0010896) | 4.08875104 |
| 55 | branched-chain amino acid catabolic process (GO:0009083) | 4.05025698 |
| 56 | aldehyde catabolic process (GO:0046185) | 4.04062209 |
| 57 | deoxyribose phosphate catabolic process (GO:0046386) | 4.03970623 |
| 58 | high-density lipoprotein particle remodeling (GO:0034375) | 4.00010444 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 3.97735330 |
| 60 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.97276776 |
| 61 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.97276776 |
| 62 | ethanol oxidation (GO:0006069) | 3.94944066 |
| 63 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.94624740 |
| 64 | 2-oxoglutarate metabolic process (GO:0006103) | 3.93548062 |
| 65 | ribosomal small subunit assembly (GO:0000028) | 3.93008072 |
| 66 | bile acid metabolic process (GO:0008206) | 3.91959913 |
| 67 | fatty acid oxidation (GO:0019395) | 3.91829589 |
| 68 | nitrogen cycle metabolic process (GO:0071941) | 3.91429911 |
| 69 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.90148753 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 3.87897246 |
| 71 | branched-chain amino acid metabolic process (GO:0009081) | 3.87093391 |
| 72 | negative regulation of fibrinolysis (GO:0051918) | 3.85998442 |
| 73 | complement activation, alternative pathway (GO:0006957) | 3.85995181 |
| 74 | fatty acid catabolic process (GO:0009062) | 3.85387332 |
| 75 | ketone body metabolic process (GO:1902224) | 3.85219706 |
| 76 | lipid oxidation (GO:0034440) | 3.83638675 |
| 77 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.83032505 |
| 78 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.82507138 |
| 79 | urate metabolic process (GO:0046415) | 3.82281544 |
| 80 | drug transmembrane transport (GO:0006855) | 3.82101886 |
| 81 | regulation of protein activation cascade (GO:2000257) | 3.80780076 |
| 82 | DNA deamination (GO:0045006) | 3.80491727 |
| 83 | glycine metabolic process (GO:0006544) | 3.80265294 |
| 84 | monocarboxylic acid catabolic process (GO:0072329) | 3.78493828 |
| 85 | cytochrome complex assembly (GO:0017004) | 3.78455297 |
| 86 | coenzyme catabolic process (GO:0009109) | 3.78438069 |
| 87 | organic acid catabolic process (GO:0016054) | 3.76770379 |
| 88 | carboxylic acid catabolic process (GO:0046395) | 3.76770379 |
| 89 | protein carboxylation (GO:0018214) | 3.76753465 |
| 90 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.76753465 |
| 91 | viral transcription (GO:0019083) | 3.75442862 |
| 92 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.73145216 |
| 93 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.73145216 |
| 94 | tyrosine metabolic process (GO:0006570) | 3.71618949 |
| 95 | aspartate family amino acid catabolic process (GO:0009068) | 3.70698871 |
| 96 | regulation of cholesterol esterification (GO:0010872) | 3.70639805 |
| 97 | regulation of fibrinolysis (GO:0051917) | 3.70012562 |
| 98 | GDP-mannose metabolic process (GO:0019673) | 3.68559369 |
| 99 | carnitine metabolic process (GO:0009437) | 3.67393571 |
| 100 | acylglycerol homeostasis (GO:0055090) | 3.67315940 |
| 101 | triglyceride homeostasis (GO:0070328) | 3.67315940 |
| 102 | indolalkylamine metabolic process (GO:0006586) | 3.66366029 |
| 103 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.66249848 |
| 104 | protein targeting to mitochondrion (GO:0006626) | 3.66163160 |
| 105 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.65619293 |
| 106 | negative regulation of ligase activity (GO:0051352) | 3.65619293 |
| 107 | amine catabolic process (GO:0009310) | 3.65451286 |
| 108 | cellular biogenic amine catabolic process (GO:0042402) | 3.65451286 |
| 109 | base-excision repair, AP site formation (GO:0006285) | 3.65291347 |
| 110 | cellular modified amino acid catabolic process (GO:0042219) | 3.65279882 |
| 111 | acetyl-CoA metabolic process (GO:0006084) | 3.64502850 |
| 112 | serine family amino acid biosynthetic process (GO:0009070) | 3.64275047 |
| 113 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.63068405 |
| 114 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.61063042 |
| 115 | translational termination (GO:0006415) | 3.60983870 |
| 116 | benzene-containing compound metabolic process (GO:0042537) | 3.60655774 |
| 117 | negative regulation of sterol transport (GO:0032372) | 3.60396290 |
| 118 | negative regulation of cholesterol transport (GO:0032375) | 3.60396290 |
| 119 | regulation of complement activation (GO:0030449) | 3.57867443 |
| 120 | respiratory chain complex IV assembly (GO:0008535) | 3.56633679 |
| 121 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.56427636 |
| 122 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.51783345 |
| 123 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.51783345 |
| 124 | maturation of SSU-rRNA (GO:0030490) | 3.51121686 |
| 125 | cotranslational protein targeting to membrane (GO:0006613) | 3.50337790 |
| 126 | ATP biosynthetic process (GO:0006754) | 3.50034523 |
| 127 | deoxyribose phosphate metabolic process (GO:0019692) | 3.50028209 |
| 128 | protein targeting to ER (GO:0045047) | 3.49519627 |
| 129 | iron-sulfur cluster assembly (GO:0016226) | 3.48883207 |
| 130 | metallo-sulfur cluster assembly (GO:0031163) | 3.48883207 |
| 131 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.48139571 |
| 132 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.48139571 |
| 133 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.48139571 |
| 134 | protein-lipid complex remodeling (GO:0034368) | 3.47410793 |
| 135 | macromolecular complex remodeling (GO:0034367) | 3.47410793 |
| 136 | plasma lipoprotein particle remodeling (GO:0034369) | 3.47410793 |
| 137 | establishment of protein localization to mitochondrion (GO:0072655) | 3.47024182 |
| 138 | cellular glucuronidation (GO:0052695) | 3.46206063 |
| 139 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.46135095 |
| 140 | protein neddylation (GO:0045116) | 3.43276128 |
| 141 | protein localization to endoplasmic reticulum (GO:0070972) | 3.42600074 |
| 142 | drug transport (GO:0015893) | 3.42249115 |
| 143 | reverse cholesterol transport (GO:0043691) | 3.42225015 |
| 144 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.41233640 |
| 145 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.41233640 |
| 146 | translational elongation (GO:0006414) | 3.38988215 |
| 147 | glutamate metabolic process (GO:0006536) | 3.38752400 |
| 148 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.38160376 |
| 149 | flavonoid metabolic process (GO:0009812) | 3.37051825 |
| 150 | response to mercury ion (GO:0046689) | 3.35202469 |
| 151 | oxidative phosphorylation (GO:0006119) | 3.34165866 |
| 152 | imidazole-containing compound metabolic process (GO:0052803) | 3.34165724 |
| 153 | NAD biosynthetic process (GO:0009435) | 3.33420132 |
| 154 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.32452865 |
| 155 | cofactor catabolic process (GO:0051187) | 3.32419704 |
| 156 | protein localization to mitochondrion (GO:0070585) | 3.31950646 |
| 157 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.30446729 |
| 158 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.29699526 |
| 159 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.29379874 |
| 160 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.29379874 |
| 161 | response to nitrosative stress (GO:0051409) | 3.29362150 |
| 162 | drug catabolic process (GO:0042737) | 3.29234814 |
| 163 | phospholipid efflux (GO:0033700) | 3.29219765 |
| 164 | arginine metabolic process (GO:0006525) | 3.27970328 |
| 165 | blood coagulation, intrinsic pathway (GO:0007597) | 3.26582411 |
| 166 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.24917558 |
| 167 | plasma lipoprotein particle clearance (GO:0034381) | 3.23520486 |
| 168 | tricarboxylic acid metabolic process (GO:0072350) | 3.23360155 |
| 169 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.22914332 |
| 170 | oxaloacetate metabolic process (GO:0006107) | 3.22803268 |
| 171 | deoxyribonucleotide metabolic process (GO:0009262) | 3.22565762 |
| 172 | glucuronate metabolic process (GO:0019585) | 3.22543780 |
| 173 | uronic acid metabolic process (GO:0006063) | 3.22543780 |
| 174 | small molecule catabolic process (GO:0044282) | 3.22008728 |
| 175 | hydrogen ion transmembrane transport (GO:1902600) | 3.20171912 |
| 176 | aerobic respiration (GO:0009060) | 3.20053911 |
| 177 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.17015367 |
| 178 | translation (GO:0006412) | 3.16737458 |
| 179 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.15265404 |
| 180 | negative regulation of B cell apoptotic process (GO:0002903) | 3.14708451 |
| 181 | mitochondrial transport (GO:0006839) | 3.13576605 |
| 182 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.13147106 |
| 183 | termination of RNA polymerase III transcription (GO:0006386) | 3.13147106 |
| 184 | pseudouridine synthesis (GO:0001522) | 3.08570953 |
| 185 | positive regulation of ligase activity (GO:0051351) | 3.06214056 |
| 186 | cellular component biogenesis (GO:0044085) | 3.05122572 |
| 187 | purine nucleotide salvage (GO:0032261) | 3.04135197 |
| 188 | viral life cycle (GO:0019058) | 3.01189077 |
| 189 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.99081905 |
| 190 | regulation of cellular amine metabolic process (GO:0033238) | 2.95622251 |
| 191 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.95461513 |
| 192 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.94171753 |
| 193 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.87441992 |
| 194 | proton transport (GO:0015992) | 2.83666066 |
| 195 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.82824654 |
| 196 | ubiquinone biosynthetic process (GO:0006744) | 2.81883416 |
| 197 | mannosylation (GO:0097502) | 2.81584546 |
| 198 | cellular protein complex disassembly (GO:0043624) | 2.80643976 |
| 199 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.80035341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.08153549 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.15157369 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.86728032 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.39676695 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.00226718 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.43486680 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.37131641 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.67355561 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.48514017 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.77766690 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.64992454 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.41950395 |
| 13 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.40364698 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.36294336 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19898120 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.97209272 |
| 17 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.91943123 |
| 18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.90575672 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.85547189 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.83102900 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82221298 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.75607408 |
| 23 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.72510173 |
| 24 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.64556440 |
| 25 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.63411618 |
| 26 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.62777424 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.60275034 |
| 28 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.59399494 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54704355 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.51473197 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47594649 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.47421329 |
| 33 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.46961388 |
| 34 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.46676101 |
| 35 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45980583 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43518765 |
| 37 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42356417 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41395962 |
| 39 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.39623075 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39383683 |
| 41 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.39098618 |
| 42 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.36438561 |
| 43 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.35778389 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.34365294 |
| 45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33968038 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.33508694 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32435707 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30780094 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29603795 |
| 50 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.29048238 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27006076 |
| 52 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.26078268 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25451330 |
| 54 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.25061566 |
| 55 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24242436 |
| 56 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23745773 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22755499 |
| 58 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.19348231 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.18454882 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18003826 |
| 61 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15888061 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15292410 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13076916 |
| 64 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.12192368 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11793687 |
| 66 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11554584 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10609506 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10078081 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09959521 |
| 70 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09301540 |
| 71 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.09016263 |
| 72 | P68_20966046_ChIP-Seq_HELA_Human | 1.08026171 |
| 73 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07327874 |
| 74 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.06455614 |
| 75 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05648376 |
| 76 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.05420709 |
| 77 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04720864 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04551814 |
| 79 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04274114 |
| 80 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03849729 |
| 81 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03416577 |
| 82 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03342143 |
| 83 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.01691451 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00916140 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00440682 |
| 86 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.99554364 |
| 87 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.99308431 |
| 88 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98988732 |
| 89 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98936726 |
| 90 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97428560 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95879432 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93222009 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92653558 |
| 94 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92244656 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92047382 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91907320 |
| 97 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91800568 |
| 98 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.91178643 |
| 99 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.90860830 |
| 100 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.90760383 |
| 101 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89814700 |
| 102 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.89444235 |
| 103 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89407803 |
| 104 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88650224 |
| 105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88051904 |
| 106 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.87900080 |
| 107 | P300_27268052_Chip-Seq_Bcells_Human | 0.87344319 |
| 108 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.87045608 |
| 109 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.86605215 |
| 110 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.86233428 |
| 111 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.86153257 |
| 112 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.86031931 |
| 113 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.84694084 |
| 114 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.84194819 |
| 115 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.83752664 |
| 116 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.82444318 |
| 117 | AR_20517297_ChIP-Seq_VCAP_Human | 0.81453920 |
| 118 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80669794 |
| 119 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80083022 |
| 120 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.79375794 |
| 121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78710659 |
| 122 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.78073550 |
| 123 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77550349 |
| 124 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.77312648 |
| 125 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.76891532 |
| 126 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.76068244 |
| 127 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.74938687 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74442450 |
| 129 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.74161615 |
| 130 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.73890080 |
| 131 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73089546 |
| 132 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73060259 |
| 133 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.72417002 |
| 134 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72008535 |
| 135 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.71740323 |
| 136 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.70137528 |
| 137 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69873864 |
| 138 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67974710 |
| 139 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.67723833 |
| 140 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67220460 |
| 141 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66713301 |
| 142 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.66624174 |
| 143 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65172622 |
| 144 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.63949414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.09630600 |
| 2 | MP0005360_urolithiasis | 6.70650608 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.33837511 |
| 4 | MP0005365_abnormal_bile_salt | 5.22231314 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.48684556 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.37532073 |
| 7 | MP0003195_calcinosis | 3.24877892 |
| 8 | MP0005332_abnormal_amino_acid | 3.13801627 |
| 9 | MP0003252_abnormal_bile_duct | 3.07925093 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.00266229 |
| 11 | MP0000372_irregular_coat_pigmentation | 2.89016224 |
| 12 | MP0009840_abnormal_foam_cell | 2.84796403 |
| 13 | MP0005083_abnormal_biliary_tract | 2.59696116 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.42268080 |
| 15 | MP0003186_abnormal_redox_activity | 2.40489781 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.40359247 |
| 17 | MP0008058_abnormal_DNA_repair | 2.23886250 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 2.15113890 |
| 19 | MP0003786_premature_aging | 2.14282352 |
| 20 | MP0001764_abnormal_homeostasis | 2.12110049 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 2.06572090 |
| 22 | MP0002653_abnormal_ependyma_morphology | 2.04100681 |
| 23 | MP0003693_abnormal_embryo_hatching | 2.01679659 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.99205038 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.97535089 |
| 26 | MP0002163_abnormal_gland_morphology | 1.92791124 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.91724350 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.90686496 |
| 29 | MP0000609_abnormal_liver_physiology | 1.88431807 |
| 30 | MP0001905_abnormal_dopamine_level | 1.79916561 |
| 31 | MP0002234_abnormal_pharynx_morphology | 1.79895050 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.79764145 |
| 33 | MP0010094_abnormal_chromosome_stability | 1.70373567 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 1.68685305 |
| 35 | MP0008932_abnormal_embryonic_tissue | 1.64400072 |
| 36 | MP0008789_abnormal_olfactory_epithelium | 1.62678031 |
| 37 | MP0009697_abnormal_copulation | 1.61838573 |
| 38 | MP0003868_abnormal_feces_composition | 1.59281290 |
| 39 | MP0004957_abnormal_blastocyst_morpholog | 1.57108722 |
| 40 | MP0001727_abnormal_embryo_implantation | 1.57002215 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 1.56828711 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.55954463 |
| 43 | MP0005670_abnormal_white_adipose | 1.55609930 |
| 44 | MP0003011_delayed_dark_adaptation | 1.55460581 |
| 45 | MP0005379_endocrine/exocrine_gland_phen | 1.51498158 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.49215477 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.47546526 |
| 48 | MP0002822_catalepsy | 1.46716548 |
| 49 | MP0010030_abnormal_orbit_morphology | 1.45590344 |
| 50 | MP0000358_abnormal_cell_content/ | 1.44544498 |
| 51 | MP0005671_abnormal_response_to | 1.39412762 |
| 52 | MP0001529_abnormal_vocalization | 1.39306032 |
| 53 | MP0006292_abnormal_olfactory_placode | 1.31929316 |
| 54 | MP0003646_muscle_fatigue | 1.30782257 |
| 55 | MP0005451_abnormal_body_composition | 1.26179506 |
| 56 | MP0006035_abnormal_mitochondrial_morpho | 1.25629938 |
| 57 | MP0001919_abnormal_reproductive_system | 1.23749448 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.23623969 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 1.23423115 |
| 60 | MP0004043_abnormal_pH_regulation | 1.19903794 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.19671250 |
| 62 | MP0003111_abnormal_nucleus_morphology | 1.19126139 |
| 63 | MP0000598_abnormal_liver_morphology | 1.15320902 |
| 64 | MP0001756_abnormal_urination | 1.13975375 |
| 65 | MP0005389_reproductive_system_phenotype | 1.12604105 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 1.12079051 |
| 67 | MP0003077_abnormal_cell_cycle | 1.10917658 |
| 68 | MP0008469_abnormal_protein_level | 1.10238639 |
| 69 | MP0009379_abnormal_foot_pigmentation | 1.09974561 |
| 70 | MP0004130_abnormal_muscle_cell | 1.06219213 |
| 71 | MP0008995_early_reproductive_senescence | 1.05975472 |
| 72 | MP0009764_decreased_sensitivity_to | 1.05949816 |
| 73 | MP0003724_increased_susceptibility_to | 1.04015037 |
| 74 | MP0005646_abnormal_pituitary_gland | 1.01513155 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 1.01337254 |
| 76 | MP0004142_abnormal_muscle_tone | 0.99853757 |
| 77 | MP0005266_abnormal_metabolism | 0.99853511 |
| 78 | MP0005410_abnormal_fertilization | 0.99813294 |
| 79 | MP0003075_altered_response_to | 0.99236193 |
| 80 | MP0003123_paternal_imprinting | 0.99160281 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.99105189 |
| 82 | MP0009642_abnormal_blood_homeostasis | 0.98776721 |
| 83 | MP0009763_increased_sensitivity_to | 0.97294445 |
| 84 | MP0008007_abnormal_cellular_replicative | 0.96980894 |
| 85 | MP0005376_homeostasis/metabolism_phenot | 0.96325437 |
| 86 | MP0005330_cardiomyopathy | 0.96040507 |
| 87 | MP0002160_abnormal_reproductive_system | 0.94926201 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.94098930 |
| 89 | MP0005535_abnormal_body_temperature | 0.90648663 |
| 90 | MP0005647_abnormal_sex_gland | 0.88391979 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 0.87768558 |
| 92 | MP0001984_abnormal_olfaction | 0.87745007 |
| 93 | MP0005408_hypopigmentation | 0.87461816 |
| 94 | MP0003137_abnormal_impulse_conducting | 0.86294809 |
| 95 | MP0005499_abnormal_olfactory_system | 0.85986316 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.85986316 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.83727970 |
| 98 | MP0004147_increased_porphyrin_level | 0.81972630 |
| 99 | MP0005220_abnormal_exocrine_pancreas | 0.81892951 |
| 100 | MP0002210_abnormal_sex_determination | 0.80990247 |
| 101 | MP0002090_abnormal_vision | 0.79953607 |
| 102 | MP0002019_abnormal_tumor_incidence | 0.79837714 |
| 103 | MP0005253_abnormal_eye_physiology | 0.79500901 |
| 104 | MP0010368_abnormal_lymphatic_system | 0.79449639 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 0.79215347 |
| 106 | MP0000639_abnormal_adrenal_gland | 0.79094712 |
| 107 | MP0001835_abnormal_antigen_presentation | 0.78846799 |
| 108 | MP0001145_abnormal_male_reproductive | 0.76373368 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.75660694 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.75488791 |
| 111 | MP0001765_abnormal_ion_homeostasis | 0.74782639 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.74684055 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.74032833 |
| 114 | MP0002971_abnormal_brown_adipose | 0.73750472 |
| 115 | MP0001853_heart_inflammation | 0.73616968 |
| 116 | MP0000750_abnormal_muscle_regeneration | 0.73491783 |
| 117 | MP0001929_abnormal_gametogenesis | 0.72954969 |
| 118 | MP0000653_abnormal_sex_gland | 0.72532810 |
| 119 | MP0001881_abnormal_mammary_gland | 0.72507516 |
| 120 | MP0002938_white_spotting | 0.69513202 |
| 121 | MP0005334_abnormal_fat_pad | 0.69374273 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.69250002 |
| 123 | MP0000749_muscle_degeneration | 0.63574574 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.62151716 |
| 125 | MP0009785_altered_susceptibility_to | 0.59185333 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.59009382 |
| 127 | MP0004084_abnormal_cardiac_muscle | 0.55205797 |
| 128 | MP0004215_abnormal_myocardial_fiber | 0.55197616 |
| 129 | MP0004036_abnormal_muscle_relaxation | 0.55190029 |
| 130 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54578834 |
| 131 | MP0000343_altered_response_to | 0.54202169 |
| 132 | MP0002132_abnormal_respiratory_system | 0.53852733 |
| 133 | MP0003718_maternal_effect | 0.52539979 |
| 134 | MP0003953_abnormal_hormone_level | 0.51738512 |
| 135 | MP0002928_abnormal_bile_duct | 0.49853813 |
| 136 | MP0001661_extended_life_span | 0.49759432 |
| 137 | MP0005165_increased_susceptibility_to | 0.48563932 |
| 138 | MP0001845_abnormal_inflammatory_respons | 0.47809383 |
| 139 | MP0002269_muscular_atrophy | 0.47715226 |
| 140 | MP0005385_cardiovascular_system_phenoty | 0.46645048 |
| 141 | MP0001544_abnormal_cardiovascular_syste | 0.46645048 |
| 142 | MP0003436_decreased_susceptibility_to | 0.46238041 |
| 143 | MP0008872_abnormal_physiological_respon | 0.45632608 |
| 144 | MP0003959_abnormal_lean_body | 0.44462608 |
| 145 | MP0008873_increased_physiological_sensi | 0.43591727 |
| 146 | MP0002970_abnormal_white_adipose | 0.43145733 |
| 147 | MP0005448_abnormal_energy_balance | 0.42623851 |
| 148 | MP0000604_amyloidosis | 0.41696680 |
| 149 | MP0008775_abnormal_heart_ventricle | 0.41205959 |
| 150 | MP0005166_decreased_susceptibility_to | 0.40141285 |
| 151 | MP0002135_abnormal_kidney_morphology | 0.38176388 |
| 152 | MP0005025_abnormal_response_to | 0.37667667 |
| 153 | MP0005395_other_phenotype | 0.37054577 |
| 154 | MP0002332_abnormal_exercise_endurance | 0.35675700 |
| 155 | MP0002254_reproductive_system_inflammat | 0.35665252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.17033849 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.87798501 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.56778465 |
| 4 | Xanthomatosis (HP:0000991) | 4.44833707 |
| 5 | Hyperglycinuria (HP:0003108) | 4.42556434 |
| 6 | Hyperammonemia (HP:0001987) | 4.42031875 |
| 7 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.39099773 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.32023912 |
| 9 | Ketosis (HP:0001946) | 4.30809730 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.28518180 |
| 11 | Deep venous thrombosis (HP:0002625) | 4.26090958 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.12659982 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.06450214 |
| 14 | Generalized aminoaciduria (HP:0002909) | 4.03741027 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 3.99381009 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99381009 |
| 17 | Hepatic necrosis (HP:0002605) | 3.88181526 |
| 18 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.87449955 |
| 19 | Dicarboxylic aciduria (HP:0003215) | 3.87449955 |
| 20 | Hyperglycinemia (HP:0002154) | 3.85858824 |
| 21 | Ketoacidosis (HP:0001993) | 3.80261685 |
| 22 | Cerebral edema (HP:0002181) | 3.68651048 |
| 23 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.67552971 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61155381 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.44852812 |
| 26 | Acute encephalopathy (HP:0006846) | 3.43904487 |
| 27 | Lethargy (HP:0001254) | 3.37541886 |
| 28 | Delayed CNS myelination (HP:0002188) | 3.25086981 |
| 29 | Hepatocellular necrosis (HP:0001404) | 3.23425912 |
| 30 | Increased muscle lipid content (HP:0009058) | 3.21554259 |
| 31 | Proximal tubulopathy (HP:0000114) | 3.21043685 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.20471643 |
| 33 | Metabolic acidosis (HP:0001942) | 3.19662410 |
| 34 | Type I transferrin isoform profile (HP:0003642) | 3.16648022 |
| 35 | Joint hemorrhage (HP:0005261) | 3.10891969 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.09296011 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.06659603 |
| 38 | Complement deficiency (HP:0004431) | 3.06595551 |
| 39 | Glycosuria (HP:0003076) | 3.04260290 |
| 40 | Abnormality of urine glucose concentration (HP:0011016) | 3.04260290 |
| 41 | Abnormality of methionine metabolism (HP:0010901) | 3.03939860 |
| 42 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.02164581 |
| 43 | Gout (HP:0001997) | 3.01287790 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.99474473 |
| 45 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.95436947 |
| 46 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.95436947 |
| 47 | Hyperbilirubinemia (HP:0002904) | 2.94552762 |
| 48 | Increased intramyocellular lipid droplets (HP:0012240) | 2.90994740 |
| 49 | Acute necrotizing encephalopathy (HP:0006965) | 2.89845764 |
| 50 | Hypoalphalipoproteinemia (HP:0003233) | 2.88944483 |
| 51 | Lactic acidosis (HP:0003128) | 2.88039430 |
| 52 | Mitochondrial inheritance (HP:0001427) | 2.87733391 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.86139921 |
| 54 | Vomiting (HP:0002013) | 2.82002605 |
| 55 | Fat malabsorption (HP:0002630) | 2.81563627 |
| 56 | Abnormality of the common coagulation pathway (HP:0010990) | 2.80407818 |
| 57 | Exertional dyspnea (HP:0002875) | 2.77090327 |
| 58 | Lipid accumulation in hepatocytes (HP:0006561) | 2.74920068 |
| 59 | Increased CSF lactate (HP:0002490) | 2.72960065 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.72671300 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 2.72590312 |
| 62 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.72428335 |
| 63 | Nausea (HP:0002018) | 2.70616543 |
| 64 | Epidermoid cyst (HP:0200040) | 2.69871617 |
| 65 | Cerebral palsy (HP:0100021) | 2.67637048 |
| 66 | Abnormal protein glycosylation (HP:0012346) | 2.66766261 |
| 67 | Abnormal glycosylation (HP:0012345) | 2.66766261 |
| 68 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.66766261 |
| 69 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.66766261 |
| 70 | Reticulocytopenia (HP:0001896) | 2.58340568 |
| 71 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.49225726 |
| 72 | Leukodystrophy (HP:0002415) | 2.46793468 |
| 73 | Progressive microcephaly (HP:0000253) | 2.45362227 |
| 74 | Optic disc pallor (HP:0000543) | 2.43566650 |
| 75 | Renal cortical cysts (HP:0000803) | 2.43348682 |
| 76 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.43178110 |
| 77 | Late onset (HP:0003584) | 2.43034740 |
| 78 | Increased serum lactate (HP:0002151) | 2.37227695 |
| 79 | Microretrognathia (HP:0000308) | 2.36699642 |
| 80 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.35017879 |
| 81 | Ragged-red muscle fibers (HP:0003200) | 2.34150378 |
| 82 | Aplastic anemia (HP:0001915) | 2.33566630 |
| 83 | Abnormality of renal resorption (HP:0011038) | 2.33299319 |
| 84 | Alkalosis (HP:0001948) | 2.32862227 |
| 85 | Respiratory difficulties (HP:0002880) | 2.32134845 |
| 86 | Myoglobinuria (HP:0002913) | 2.30251130 |
| 87 | Methylmalonic aciduria (HP:0012120) | 2.29903423 |
| 88 | Progressive macrocephaly (HP:0004481) | 2.28525757 |
| 89 | Conjugated hyperbilirubinemia (HP:0002908) | 2.27293599 |
| 90 | Macrocytic anemia (HP:0001972) | 2.27286664 |
| 91 | Hypercholesterolemia (HP:0003124) | 2.25649906 |
| 92 | Reduced antithrombin III activity (HP:0001976) | 2.24816258 |
| 93 | Emotional lability (HP:0000712) | 2.24058289 |
| 94 | Microvesicular hepatic steatosis (HP:0001414) | 2.23802396 |
| 95 | Hyperphosphaturia (HP:0003109) | 2.23466779 |
| 96 | 3-Methylglutaconic aciduria (HP:0003535) | 2.22414138 |
| 97 | Increased hepatocellular lipid droplets (HP:0006565) | 2.22207042 |
| 98 | Steatorrhea (HP:0002570) | 2.21846488 |
| 99 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21146741 |
| 100 | Renal Fanconi syndrome (HP:0001994) | 2.20401753 |
| 101 | Increased purine levels (HP:0004368) | 2.20203328 |
| 102 | Hyperuricemia (HP:0002149) | 2.20203328 |
| 103 | Abnormal number of erythroid precursors (HP:0012131) | 2.18300985 |
| 104 | Abnormality of complement system (HP:0005339) | 2.18036442 |
| 105 | Pancreatitis (HP:0001733) | 2.18034088 |
| 106 | Pancytopenia (HP:0001876) | 2.13590975 |
| 107 | Rhabdomyolysis (HP:0003201) | 2.09600024 |
| 108 | Brushfield spots (HP:0001088) | 2.07719380 |
| 109 | Respiratory failure (HP:0002878) | 2.03336584 |
| 110 | Irritability (HP:0000737) | 2.03096454 |
| 111 | Vascular calcification (HP:0004934) | 2.02795204 |
| 112 | Hypoglycemic seizures (HP:0002173) | 2.02534122 |
| 113 | Opisthotonus (HP:0002179) | 2.01794398 |
| 114 | CNS demyelination (HP:0007305) | 1.99748540 |
| 115 | Testicular atrophy (HP:0000029) | 1.99331228 |
| 116 | Hyperthyroidism (HP:0000836) | 1.99065094 |
| 117 | Abnormality of glycolysis (HP:0004366) | 1.98878164 |
| 118 | Increased serum pyruvate (HP:0003542) | 1.98878164 |
| 119 | Muscle fiber atrophy (HP:0100295) | 1.98533697 |
| 120 | Neonatal onset (HP:0003623) | 1.97938545 |
| 121 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.97201495 |
| 122 | Gliosis (HP:0002171) | 1.94634786 |
| 123 | Hepatocellular carcinoma (HP:0001402) | 1.93432432 |
| 124 | Palpitations (HP:0001962) | 1.92264734 |
| 125 | Spontaneous abortion (HP:0005268) | 1.90606789 |
| 126 | Elevated hepatic transaminases (HP:0002910) | 1.90467795 |
| 127 | Exercise intolerance (HP:0003546) | 1.90218703 |
| 128 | Hydroxyprolinuria (HP:0003080) | 1.89799511 |
| 129 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87124887 |
| 130 | Prolonged neonatal jaundice (HP:0006579) | 1.86227757 |
| 131 | X-linked dominant inheritance (HP:0001423) | 1.84314280 |
| 132 | Hypokinesia (HP:0002375) | 1.84226643 |
| 133 | Petechiae (HP:0000967) | 1.82320593 |
| 134 | Abnormality of the anterior horn cell (HP:0006802) | 1.80193991 |
| 135 | Degeneration of anterior horn cells (HP:0002398) | 1.80193991 |
| 136 | Congenital malformation of the right heart (HP:0011723) | 1.78335304 |
| 137 | Double outlet right ventricle (HP:0001719) | 1.78335304 |
| 138 | Multiple enchondromatosis (HP:0005701) | 1.77044797 |
| 139 | Progressive muscle weakness (HP:0003323) | 1.74729534 |
| 140 | Cleft eyelid (HP:0000625) | 1.70165003 |
| 141 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67577197 |
| 142 | Medial flaring of the eyebrow (HP:0010747) | 1.65573485 |
| 143 | Hypertensive crisis (HP:0100735) | 1.64763430 |
| 144 | Agammaglobulinemia (HP:0004432) | 1.64732207 |
| 145 | Obstructive lung disease (HP:0006536) | 1.63360273 |
| 146 | Chronic obstructive pulmonary disease (HP:0006510) | 1.63360273 |
| 147 | Abnormal urine phosphate concentration (HP:0012599) | 1.62285557 |
| 148 | Absent thumb (HP:0009777) | 1.61010747 |
| 149 | Acute hepatic failure (HP:0006554) | 1.60908765 |
| 150 | Abnormal pupillary function (HP:0007686) | 1.60196288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.35984446 |
| 2 | VRK2 | 6.59381331 |
| 3 | NME2 | 3.46619952 |
| 4 | TESK1 | 3.21683414 |
| 5 | ERN1 | 3.10257745 |
| 6 | BUB1 | 2.70352185 |
| 7 | STK16 | 2.67626640 |
| 8 | FLT3 | 2.64402288 |
| 9 | MYLK | 2.55990135 |
| 10 | LIMK1 | 2.28677668 |
| 11 | KDR | 2.25156515 |
| 12 | SCYL2 | 2.15914768 |
| 13 | FGFR4 | 2.06779007 |
| 14 | SIK1 | 1.99891614 |
| 15 | PINK1 | 1.96625670 |
| 16 | MUSK | 1.86888911 |
| 17 | WNK4 | 1.76705495 |
| 18 | DAPK1 | 1.74495793 |
| 19 | PKN2 | 1.73047769 |
| 20 | TIE1 | 1.70974931 |
| 21 | CSNK1G3 | 1.63548180 |
| 22 | CDC7 | 1.62730229 |
| 23 | WNK3 | 1.60733366 |
| 24 | TAF1 | 1.59704679 |
| 25 | TAOK3 | 1.57198100 |
| 26 | IRAK3 | 1.55113365 |
| 27 | MAP4K2 | 1.54348825 |
| 28 | SMG1 | 1.52828972 |
| 29 | INSRR | 1.50037450 |
| 30 | STK38L | 1.48888112 |
| 31 | ARAF | 1.48812484 |
| 32 | MST1R | 1.48384021 |
| 33 | ABL2 | 1.42402983 |
| 34 | MAP3K11 | 1.42220314 |
| 35 | NUAK1 | 1.40667047 |
| 36 | TYK2 | 1.36249652 |
| 37 | MAPK15 | 1.31160671 |
| 38 | PIK3CG | 1.31087902 |
| 39 | MAP2K6 | 1.28140344 |
| 40 | CSNK1A1L | 1.26001895 |
| 41 | TBK1 | 1.24923305 |
| 42 | AURKA | 1.23011986 |
| 43 | TRIB3 | 1.21592343 |
| 44 | MAP2K3 | 1.20209122 |
| 45 | TEC | 1.17774274 |
| 46 | CSNK1G2 | 1.17712795 |
| 47 | MST4 | 1.17417629 |
| 48 | CSNK1G1 | 1.16582198 |
| 49 | MAPK11 | 1.12859439 |
| 50 | SRPK1 | 1.12453041 |
| 51 | EIF2AK3 | 1.11844711 |
| 52 | TLK1 | 1.10528779 |
| 53 | NEK9 | 1.08923748 |
| 54 | DYRK2 | 1.06348854 |
| 55 | PRKG2 | 1.06068379 |
| 56 | KIT | 1.05978465 |
| 57 | EIF2AK1 | 1.02320054 |
| 58 | CDK8 | 1.00540252 |
| 59 | VRK1 | 0.98510020 |
| 60 | OBSCN | 0.98253832 |
| 61 | TGFBR2 | 0.97974033 |
| 62 | MAPKAPK3 | 0.97531046 |
| 63 | CCNB1 | 0.92195504 |
| 64 | DYRK3 | 0.90456193 |
| 65 | PDK4 | 0.90121796 |
| 66 | PDK3 | 0.90121796 |
| 67 | MAP3K12 | 0.89622607 |
| 68 | MAP2K2 | 0.87679468 |
| 69 | MAP3K7 | 0.87146004 |
| 70 | BTK | 0.86515719 |
| 71 | NEK1 | 0.86005355 |
| 72 | RPS6KA5 | 0.85446133 |
| 73 | MAP2K7 | 0.84038669 |
| 74 | MAPKAPK5 | 0.83339561 |
| 75 | PRKAA2 | 0.82805525 |
| 76 | GRK5 | 0.82673832 |
| 77 | MAPK4 | 0.81739524 |
| 78 | PLK1 | 0.80866864 |
| 79 | ZAP70 | 0.80658064 |
| 80 | PIM2 | 0.80530016 |
| 81 | NME1 | 0.80083132 |
| 82 | WEE1 | 0.77175308 |
| 83 | MAP4K1 | 0.76973877 |
| 84 | MAP3K3 | 0.75239986 |
| 85 | LMTK2 | 0.73221318 |
| 86 | LRRK2 | 0.72920918 |
| 87 | ILK | 0.72113010 |
| 88 | OXSR1 | 0.71736387 |
| 89 | MAP2K4 | 0.71712768 |
| 90 | JAK2 | 0.70725619 |
| 91 | AURKB | 0.69583909 |
| 92 | PIK3CA | 0.69345178 |
| 93 | IKBKE | 0.67845905 |
| 94 | IRAK1 | 0.66657150 |
| 95 | ATR | 0.66601636 |
| 96 | GRK1 | 0.66400494 |
| 97 | PBK | 0.63719759 |
| 98 | PHKG1 | 0.61449444 |
| 99 | PHKG2 | 0.61449444 |
| 100 | BRSK1 | 0.61181598 |
| 101 | PRKD3 | 0.60693524 |
| 102 | TGFBR1 | 0.59969090 |
| 103 | CAMK2G | 0.57810139 |
| 104 | CHEK2 | 0.56527863 |
| 105 | CSNK2A2 | 0.56324176 |
| 106 | ERBB4 | 0.54307323 |
| 107 | IRAK4 | 0.54049284 |
| 108 | CDK7 | 0.54019787 |
| 109 | ZAK | 0.53606145 |
| 110 | BRAF | 0.53361773 |
| 111 | TRIM28 | 0.53186734 |
| 112 | DYRK1B | 0.53158931 |
| 113 | PAK1 | 0.53100080 |
| 114 | GRK6 | 0.53024901 |
| 115 | RPS6KA4 | 0.52177217 |
| 116 | TAOK2 | 0.51423864 |
| 117 | PLK4 | 0.50707710 |
| 118 | CAMKK2 | 0.49356786 |
| 119 | MAPK12 | 0.48991025 |
| 120 | PRKCI | 0.48720548 |
| 121 | DAPK3 | 0.48583269 |
| 122 | RPS6KB2 | 0.47792827 |
| 123 | IKBKB | 0.46669763 |
| 124 | PLK3 | 0.44405838 |
| 125 | CDK19 | 0.43878502 |
| 126 | NLK | 0.43837711 |
| 127 | PRKACG | 0.43738000 |
| 128 | BLK | 0.42400733 |
| 129 | TNK2 | 0.39974665 |
| 130 | PRKAA1 | 0.39816220 |
| 131 | CAMK2D | 0.38812458 |
| 132 | CAMK1 | 0.37411781 |
| 133 | CSNK2A1 | 0.37341180 |
| 134 | ADRBK2 | 0.36390869 |
| 135 | EIF2AK2 | 0.36389343 |
| 136 | TESK2 | 0.36284559 |
| 137 | TTN | 0.35133776 |
| 138 | AKT2 | 0.34532942 |
| 139 | CDK4 | 0.34501556 |
| 140 | PRKCD | 0.34173481 |
| 141 | MATK | 0.33910399 |
| 142 | TNIK | 0.33790816 |
| 143 | CSF1R | 0.33753274 |
| 144 | IRAK2 | 0.32547583 |
| 145 | CDK14 | 0.32519460 |
| 146 | PDK2 | 0.32178604 |
| 147 | PTK6 | 0.31708614 |
| 148 | PRKCQ | 0.30563058 |
| 149 | PIM1 | 0.29333516 |
| 150 | PAK4 | 0.28769858 |
| 151 | CSNK1A1 | 0.27855100 |
| 152 | PRKCZ | 0.27647282 |
| 153 | SYK | 0.25252452 |
| 154 | CDK11A | 0.24420930 |
| 155 | BMPR1B | 0.23867805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.46856442 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.94480690 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.87721741 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.77395717 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.76657075 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.64797201 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.61997567 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.40707831 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33657094 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29619588 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.28761332 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.27906079 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.26099062 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21501915 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.18730889 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.17363918 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 2.15128548 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 2.12598646 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.96221044 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.93117709 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.90509746 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89183888 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.87553860 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.85402535 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.84039743 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80886307 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.75008533 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73132998 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70697268 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70233137 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70134191 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69393965 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69087886 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.66045907 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.59525251 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57690663 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56591618 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50519449 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49271001 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.45446213 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44736126 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.42007922 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.39994940 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39169989 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.38233595 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37491915 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.35161471 |
| 48 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.32243651 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30411613 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26342562 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23098490 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21149390 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19356934 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.18567561 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.17644180 |
| 56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.15583119 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.14709778 |
| 58 | Ribosome_Homo sapiens_hsa03010 | 1.13797921 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10439416 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06712171 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06068233 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05271951 |
| 63 | Spliceosome_Homo sapiens_hsa03040 | 1.03369482 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02383714 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 1.01330167 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98639117 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98469781 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87263093 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86776605 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.85302099 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.83816137 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.82539683 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80209792 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79586411 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78670532 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78335800 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73884717 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73744896 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70950464 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67481010 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66211844 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64217130 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.64043333 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63065688 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62701261 |
| 86 | Proteasome_Homo sapiens_hsa03050 | 0.62158326 |
| 87 | Allograft rejection_Homo sapiens_hsa05330 | 0.61874707 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58378919 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.57379740 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.55777846 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55107754 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54172814 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50676895 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49485646 |
| 95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.49340421 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48988360 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.46837573 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43711806 |
| 99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41695786 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.35350693 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34910923 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.33925805 |
| 103 | Phototransduction_Homo sapiens_hsa04744 | 0.31371965 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29467728 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23679240 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22948488 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21280748 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17351648 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.14462005 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.11522009 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.09358642 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07942952 |
| 113 | RNA polymerase_Homo sapiens_hsa03020 | 0.07278660 |
| 114 | Purine metabolism_Homo sapiens_hsa00230 | 0.06312997 |
| 115 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.04433182 |
| 116 | DNA replication_Homo sapiens_hsa03030 | 0.02077980 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0629207 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0541739 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0324467 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | -0.0323661 |
| 121 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0305661 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0228945 |
| 123 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0206984 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0010869 |

